BioNTech SE (BNTX) Reports Q2 EPS of EUR6.45
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mail
Get Alerts BNTX Hot Sheet
Join SI Premium – FREE
BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of EUR6.45. Revenue for the quarter came in at EUR3.2 billion.
The company reiterated BioNTech COVID-19 2022 vaccine revenue guidance of €13 billion to €17 billion.
For earnings history and earnings-related data on BioNTech SE (BNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Why Beijing could block the SpaceX-Tesla merger
- Iradimed Corp. (IRMD) Reports In-Line Q3 EPS
- BofA cuts mortgage insurer ratings, citing regulatory overhang; stocks drop
Create E-mail Alert Related Categories
Corporate News, Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
